Clinical Trials Study
Copyright ©The Author(s) 2020.
World J Transplant. Apr 29, 2020; 10(4): 79-89
Published online Apr 29, 2020. doi: 10.5500/wjt.v10.i4.79
Table 2 Frequency distributions for the reasons of end-stage kidney disease diagnosis
Control groupStudy group
n%n%
Diabetes and HTN735.0523.8
Type II DM210.0314.3
Glomerulonephritis210.029.5
Acute kidney failure15.014.8
HTN15.014.8
Obstructive uropathy15.014.8
Type 1 DM15.014.8
Alport’s diesese15.000.0
Alport’s disease00.014.8
Amyloidosis15.000.0
Drug toxicity15.000.0
Dysplastic kidney, HTN15.000.0
FSGS00.014.8
Kidney stones00.014.8
MPGN00.014.8
Polycystic kidney disease00.014.8
Prostate Tm, HTN, DM00.014.8
Renal cell Ca+ dysplastic kidney00.014.8
Urethral stricture15.000.0
Total20100.021100.0